161 related articles for article (PubMed ID: 33196904)
1. Impact of persistent endothelial dysfunction in an infarct-related coronary artery on future major adverse cardiovascular event occurrence in STEMI survivors.
Horikoshi T; Nakamura T; Yoshizaki T; Watanabe Y; Uematsu M; Kobayashi T; Nakamura K; Saito Y; Obata JE; Kugiyama K
Heart Vessels; 2021 Apr; 36(4):472-482. PubMed ID: 33196904
[TBL] [Abstract][Full Text] [Related]
2. Persistent Dysfunction of Coronary Endothelial Vasomotor Responses is Related to Atheroma Plaque Progression in the Infarct-Related Coronary Artery of AMI Survivors.
Horikoshi T; Obata JE; Nakamura T; Fujioka D; Watanabe Y; Nakamura K; Watanabe K; Saito Y; Kugiyama K
J Atheroscler Thromb; 2019 Dec; 26(12):1062-1074. PubMed ID: 30996201
[TBL] [Abstract][Full Text] [Related]
3. Sustained endothelial dysfunction in the infarct-related coronary artery is associated with left ventricular adverse remodeling in survivors of ST-segment elevation myocardial infarction.
Obata JE; Horikoshi T; Nakamura T; Kugiyama K
J Cardiol; 2020 Mar; 75(3):261-269. PubMed ID: 31447080
[TBL] [Abstract][Full Text] [Related]
4. Endothelial Dysfunction After ST-segment Elevation Myocardial Infarction and Long-term Outcome: A Study With Reactive Hyperemia Peripheral Artery Tonometry.
Kandhai-Ragunath JJ; Doggen CJ; Jørstad HT; Doelman C; de Wagenaar B; IJzerman MJ; Peters RJ; von Birgelen C
Rev Esp Cardiol (Engl Ed); 2016 Jul; 69(7):664-71. PubMed ID: 27068872
[TBL] [Abstract][Full Text] [Related]
5. Microvascular obstruction in non-infarct related coronary arteries is an independent predictor of major adverse cardiovascular events in patients with ST segment-elevation myocardial infarction.
Khorramirouz R; Corban MT; Yang SW; Lewis BR; Bois J; Foley T; Lerman LO; Herrmann J; Oh JK; Lerman A
Int J Cardiol; 2018 Dec; 273():22-28. PubMed ID: 30131228
[TBL] [Abstract][Full Text] [Related]
6. A simple angio-based coronary flow assessment of culprit vessels in primary percutaneous coronary intervention is associated with long-term prognosis after ST-segment-elevation myocardial infarction.
Chen G; Westra J; Yang X; Zhang Y; Luo D; Hu X; Li G; Zhou Y; Tu S; Dong H
Int J Cardiol; 2024 Aug; 409():132199. PubMed ID: 38782068
[TBL] [Abstract][Full Text] [Related]
7. Occlusion of the infarct-related coronary artery presenting as acute coronary syndrome with and without ST-elevation: impact of inflammation and outcomes in a real-world prospective cohort.
Bruno F; Adjibodou B; Obeid S; Kraler SC; Wenzl FA; Akhtar MM; Denegri A; Roffi M; Muller O; von Eckardstein A; Räber L; Templin C; Lüscher TF
Eur Heart J Qual Care Clin Outcomes; 2023 Sep; 9(6):564-574. PubMed ID: 37197909
[TBL] [Abstract][Full Text] [Related]
8. Microvascular obstruction extent predicts major adverse cardiovascular events in patients with acute myocardial infarction and preserved ejection fraction.
Galea N; Dacquino GM; Ammendola RM; Coco S; Agati L; De Luca L; Carbone I; Fedele F; Catalano C; Francone M
Eur Radiol; 2019 May; 29(5):2369-2377. PubMed ID: 30552479
[TBL] [Abstract][Full Text] [Related]
9. Impact of acute infarct-related artery patency before percutaneous coronary intervention on 30-day outcomes in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention in the EUROMAX trial.
Rakowski T; Dudek D; van 't Hof A; Ten Berg J; Soulat L; Zeymer U; Lapostolle F; Anthopoulos P; Bernstein D; Deliargyris EN; Steg PG
Eur Heart J Acute Cardiovasc Care; 2018 Sep; 7(6):514-521. PubMed ID: 28631502
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of Microvascular and Endothelial Dysfunction in the Nonculprit Territory in Patients With Acute Myocardial Infarction.
Díez-Delhoyo F; Gutiérrez-Ibañes E; Sanz-Ruiz R; Vázquez-Álvarez ME; González Saldívar H; Rivera Juárez A; Sarnago F; Martínez-Sellés M; Bermejo J; Soriano J; Elízaga J; Fernández-Avilés F
Circ Cardiovasc Interv; 2019 Feb; 12(2):e007257. PubMed ID: 30722689
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and Predictive Value of Microvascular Flow Abnormalities after Successful Contemporary Percutaneous Coronary Intervention in Acute ST-Segment Elevation Myocardial Infarction.
Aggarwal S; Xie F; High R; Pavlides G; Porter TR
J Am Soc Echocardiogr; 2018 Jun; 31(6):674-682. PubMed ID: 29525249
[TBL] [Abstract][Full Text] [Related]
12. Serial assessment of endothelial function 1, 6, and 12 months after ST-elevation myocardial infarction.
Kandhai-Ragunath JJ; Doggen CJM; van der Heijden LC; Kok MM; Zocca P; de Wagenaar B; Doelman C; Jørstad HT; Peters RJG; von Birgelen C
Heart Vessels; 2018 Sep; 33(9):978-985. PubMed ID: 29541845
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of the age, creatinine, and ejection fraction score for non-infarct-related chronic total occlusion revascularization after primary percutaneous intervention in acute ST-elevation myocardial infarction patients: A retrospective study.
Deng J; Wang X; Shi Y; Zhao X; Han Y
J Interv Cardiol; 2018 Feb; 31(1):33-40. PubMed ID: 28940388
[TBL] [Abstract][Full Text] [Related]
14. Treatment of acute myocardial infarction with sirolimus-eluting stents results in chronic endothelial dysfunction in the infarct-related coronary artery.
Obata JE; Nakamura T; Kitta Y; Kodama Y; Sano K; Kawabata K; Saitoh Y; Fujioka D; Kobayashi T; Yano T; Watanabe Y; Watanabe K; Kugiyama K
Circ Cardiovasc Interv; 2009 Oct; 2(5):384-91. PubMed ID: 20031747
[TBL] [Abstract][Full Text] [Related]
15. Impact of multivessel coronary artery disease on reperfusion success in patients with ST-elevation myocardial infarction: A substudy of the AIDA STEMI trial.
de Waha S; Eitel I; Desch S; Fuernau G; Pöss J; Schuler G; Thiele H
Eur Heart J Acute Cardiovasc Care; 2017 Oct; 6(7):592-600. PubMed ID: 26691729
[TBL] [Abstract][Full Text] [Related]
16. The Natural History of Nonculprit Lesions in STEMI: An FFR Substudy of the Compare-Acute Trial.
Piróth Z; Boxma-de Klerk BM; Omerovic E; Andréka P; Fontos G; Fülöp G; Abdel-Wahab M; Neumann FJ; Richardt G; Abdelghani M; Smits PC
JACC Cardiovasc Interv; 2020 Apr; 13(8):954-961. PubMed ID: 32327091
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of platelet/lymphocyte ratio and CAMI-STEMI score for major adverse cardiac events in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention: A prospective observational study.
Wang Y; Peng Z
Medicine (Baltimore); 2021 Aug; 100(33):e26942. PubMed ID: 34414954
[TBL] [Abstract][Full Text] [Related]
18. Angiography-guided Multivessel Percutaneous Coronary Intervention Versus Ischemia-guided Percutaneous Coronary Intervention Versus Medical Therapy in the Management of Significant Disease in Non-Infarct-related Arteries in ST-Elevation Myocardial Infarction Patients With Multivessel Coronary Disease.
Perera D; Crake T; Lee V
Crit Pathw Cardiol; 2018 Jun; 17(2):77-82. PubMed ID: 29768315
[TBL] [Abstract][Full Text] [Related]
19. Impact of infarct location and size on clinical outcome after ST-elevation myocardial infarction treated by primary percutaneous coronary intervention.
Reindl M; Holzknecht M; Tiller C; Lechner I; Schiestl M; Simma F; Pamminger M; Henninger B; Mayr A; Klug G; Bauer A; Metzler B; Reinstadler SJ
Int J Cardiol; 2020 Feb; 301():14-20. PubMed ID: 31761400
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of 500-m walk electrocardiogram test on clinical outcomes in patients with ST-segment elevation myocardial infarction.
Ohashi J; Sakakura K; Sasaki W; Taniguchi Y; Kani K; Yamamoto K; Tsukui T; Seguchi M; Wada H; Momomura SI; Fujita H
Heart Vessels; 2021 Jan; 36(1):48-57. PubMed ID: 32671463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
